Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV
Phase 2
12
about 9 months
18+
1 site in HI
About this study
This trial is testing whether tirzepatide helps with weight loss and reduces chronic inflammation in people living with HIV. Participants will receive tirzepatide, a medication, for 261 days. It aims to measure changes in weight, body composition, liver health, inflammatory markers, and other factors.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Tirzepatide
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
tirzepatide
injection (Injection)
Primary: Change in Baseline Body Weight
Secondary: Body composition, Change in Inflammatory Markers: IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, Waist circumference
Immune, Infectious